Current knowledge on exosome biogenesis and release.
Hessvik NP, Llorente A. · 2018
Read Current knowledge on exosome biogenesis and release. by Hessvik NP, Llorente A. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5756260.txt.
Introduction
Hessvik and Llorente review how exosomes form and leave cells. Exosomes are tiny membrane sacs, under 150 nanometres wide. Cells release them when an inner compartment fuses with the cell surface. Once seen as cell waste, they now count as a route for messages between cells.
The review sums up the steps that build these sacs and load their cargo. It also covers related paths such as autophagy and lysosomal release. Methods for studying exosome release get a careful look. The authors stress that much of the basic biology stays unknown. That gap matters for hopes of using exosomes in care and testing.
Catalog record
| CREATOR | Hessvik NP, Llorente A. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 79 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Current knowledge on exosome biogenesis and release By Nina Pettersen Hessvik, Alicia Llorente Published in: Cellular and Molecular Life Sciences: CMLS DOI: 10.1007/s00018-017-2595-9 ABSTRACT Abstract Exosomes are nanosized membrane vesicles released by fusion of an organelle of the endocytic pathway, the multivesicular body, with the plasma membrane. This process was discovered more than 30 years ago, and during these years, exosomes have gone from being considered as cellular waste disposal to mediate a novel mechanism of cell-to-cell communication. The exponential interest in exosomes experienced during recent years is due to their important roles in health and disease and to their potential clinical application in therapy and diagnosis. However, important aspects of the biology of exosomes remain unknown. To explore the use of exosomes in the clinic, it is essential that the basic molecular mechanisms behind the transport and function of these vesicles are better understood. We have here summarized what is presently known about how exosomes are formed and released by cells. Moreover, other cellular processes related to exosome biogenesis and release, such as autophagy and lysosomal exocytosis are presented. Finally, methodological aspects related to exosome release studies are discussed. Keywords: Autophagy, Endosomes, Exosomes, Extracellular vesicles, Lysosomes, Microvesicles, MVB biogenesis, MVBs, Release, Secretion INTRODUCTION Extracellular vesicles (EVs) were first observed 50 years ago in plasma by Wolf, who referred to them as “platelet dust” [1]. Since then, all biological fluids tested have been shown to contain vesicles, and also in vitro grown cell lines have been shown to release vesicles to different extents [2, 3]. These vesicles have received different names during the years, but today are often collectively referred as EVs. Three main types of EVs have been described based on their mechanism of release and size: exosomes (less than 150 nm in diameter), microvesicles/shedding particles and apoptotic bodies (both considered to be larger than 100 nm). The last two types of vesicles are released directly from the plasma membrane in living and dying cells, respectively, and will not be further discussed here. This review deals with the smallest of the family, the exosomes, which are vesicles that are released to the extracellular environment after fusion of late endosomes/multivesicular bodies (MVBs) with the plasma membrane (Fig. 1). This process was first visualized in rat reticulocytes in 1983 [4], and then in sheep reticulocytes in 1985 [5]. Rose Johnstone, a pioneer in the field, chose the term “exosome” in 1987 because “the process seemed to be akin to reverse endocytosis, with internal vesicular contents released in contrast to external molecules internalized in membrane-bound structures” [6, 7]. Further insight into this process has, however, mainly been acquired in recent years [8]. [Figure: Study of exosome release. Exosomes are released after fusion of MVBs with the plasma membrane. Exosomes have a complex composition of protein, nucleic acids, lipids and other metabolites. Due to their small size (<150 nm in diameter), exosomes are best visualized by electron microscopy. Though some commonly used electron microscopy methods artificially show exosomes as cup-shaped structures, exosomes are round structures. Exosomes are isolated from cell-conditioned media by several protocols that aim to concentrate the exosomal signal to be analyzed and to avoid contaminating molecules such as proteins that are secreted by other mechanisms. Once isolated, exosomes can be analyzed by several methods such as the ones included in this figure. TRPS tunable resistive pulse sensing, NTA nanoparticle tracking analysis.The figure contains parts reprinted from the Ph.D. degree of Santosh Phuyal, University of Oslo, with permission from the author] Initially, exosomes were proposed to represent cellular waste [7], and recent data also support the idea of exosomes as an alternative way of eliminating waste products to maintain cellular homeostasis [9, 10]. In addition, these vesicles are suggested to play a role in intercellular communication and have been associated with numerous physiological and pathological functions [2, 11, 12]. Interestingly, exosomes from cancer cells have been shown to promote angiogenesis, modulate the immune system and remodel the surrounding parenchymal tissue, all factors supporting tumor progression (reviewed in [13]). In particular, exosomes have been shown to participate in the generation of the pre-metastatic niche [14–16]. To release exosomes, several cellular steps need to be completed; formation of intraluminal vesicles (ILVs) in MVBs, transport of MVBs to the plasma membrane and fusion of MVBs with the plasma membrane. Several molecules have been implicated in these processes, but due to methodological challenges, it is not easy to distinguish them experimentally, and in many studies it is not clear at which step the investigated molecule/factor operates (Fig. 2). Another important question is whether all MVBs or only specific populations can fuse with the plasma membrane. In agreement with the latter possibility, it has been shown that in B-lymphocytes two pools of MVBs can be identified based on their cholesterol content, and that only MVBs with high cholesterol levels are able to fuse with the plasma membrane and release exosomes [17]. Moreover, EGF and its receptor have been shown to reach a subpopulation of MVBs that are distinct from morphologically identical vacuoles labeled with BMP (bismonoacyl glycerophosphate), also called LBPA (lysobisphosphatic acid) [18], a late endosomal marker [19]. Interestingly, several studies show that exosomes secreted from the apical and basolateral side of polarized cells differ in composition [20–22], thus also supporting the existence of different MVB populations. Furthermore, it would be interesting to learn more about the kinetics of exosome release, for example how many MVBs per hour fuse with the plasma membrane. Measurements of total exosomal protein levels and western blot (WB) analysis of specific proteins indicate that cells only release a small percentage of their content via exosomes. However, as discussed later, the extent of exosome release is cell-dependent, and it can be regulated by different cellular conditions or external factors. [Figure: Molecules shown to affect exosome biogenesis and/or release. The process that leads to secretion of exosomes can be divided in three steps; exosome biogenesis, transport of MVBs to the plasma membrane and fusion of MVBs with the plasma membrane. The step affected, or likely to be affected, by each molecule is indicated on the figure] Mass spectrometry-based proteomics and lipidomics analyses have been useful to characterize the proteome and lipidome of exosomes, respectively [23–25]. It can be expected that the composition of exosomes reflects to some extent the composition of MVBs. In fact, proteins associated with MVBs such as several endosomal sorting complex required for transport (ESCRT) proteins or CD63 have been found in exosomes, as can been seen in databases that compile information about the molecular composition of exosomes [26, 27]. Knowledge on the composition of exosomes can give us clues about the machinery involved in their release. However, due to the complex composition of exosomes, it is difficult to identify these molecules. In addition, molecules involved in the release of exosomes do not necessarily need to be incorporated into them. In this review, the process that ends with the release of exosomes has been divided into several steps (see above) for simplicity. However, it should be mentioned that in some cases the roles of a molecule in a specific step is not completely understood. In addition, a specific molecule can be involved in more than one step along the pathway